share_log

HOOKIPA Pharma | DEFA14A: Others

HOOKIPA Pharma | DEFA14A: Others

HOOKIPA Pharma | DEFA14A:其他
美股SEC公告 ·  04/26 16:45
Moomoo AI 已提取核心信息
HOOKIPA Pharma Inc. has filed a DEFA14A form with the United States Securities and Exchange Commission (SEC), indicating the submission of additional proxy soliciting materials. The filing, which is part of the regulatory requirements under Section 14(a) of the Securities Exchange Act of 1934, does not require a filing fee. This submission by HOOKIPA Pharma is a definitive additional material, suggesting that it is likely a follow-up to a previously filed proxy statement. The materials are intended for use in connection with a shareholder meeting or vote, although the specific resolutions or proposals are not detailed in the announcement.
HOOKIPA Pharma Inc. has filed a DEFA14A form with the United States Securities and Exchange Commission (SEC), indicating the submission of additional proxy soliciting materials. The filing, which is part of the regulatory requirements under Section 14(a) of the Securities Exchange Act of 1934, does not require a filing fee. This submission by HOOKIPA Pharma is a definitive additional material, suggesting that it is likely a follow-up to a previously filed proxy statement. The materials are intended for use in connection with a shareholder meeting or vote, although the specific resolutions or proposals are not detailed in the announcement.
HOOKIPA Pharma Inc. 已向美国证券交易委员会(SEC)提交了一份 DEFA14A 表格,表示将提交额外的代理招标材料。该文件是1934年《证券交易法》第14(a)条监管要求的一部分,不需要缴纳申请费。HOOKIPA Pharma提交的这份文件是明确的补充材料,表明这可能是先前提交的委托书的后续文件。尽管公告中未详细说明具体的决议或提案,但这些材料旨在用于股东大会或投票。
HOOKIPA Pharma Inc. 已向美国证券交易委员会(SEC)提交了一份 DEFA14A 表格,表示将提交额外的代理招标材料。该文件是1934年《证券交易法》第14(a)条监管要求的一部分,不需要缴纳申请费。HOOKIPA Pharma提交的这份文件是明确的补充材料,表明这可能是先前提交的委托书的后续文件。尽管公告中未详细说明具体的决议或提案,但这些材料旨在用于股东大会或投票。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息